Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.
USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks.
Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC.
Drug Trafficking
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment.
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment. J Clin Med. 2024 Oct 30; 13(21).
View in:
PubMed
authors with profiles
Ravi Salgia